CIML NK Cells With Venetoclax for AML

Clinical trial NCT06152809 · RECRUITING

Trial details

NCT number: NCT06152809
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Myeloid Leukemia Recurrent Leukemia Leukemia, Myeloid

Start date: 2024-02-20
Primary completion: 2026-11-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.